Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11622 | 902 | 28.5 | 85% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
170 | 21413 | HEAD AND NECK CANCER//LARYNGECTOMY//HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PLANNED NECK DISSECTION | Author keyword | 32 | 88% | 2% | 15 |
2 | NECK MANAGEMENT | Author keyword | 15 | 88% | 1% | 7 |
3 | NECK DISSECTION | Author keyword | 11 | 11% | 10% | 88 |
4 | METABOLIC TUMOR VOLUME | Author keyword | 3 | 20% | 2% | 15 |
5 | HEAD AND NECK NEOPLASMS EMISSION CT ECT | Author keyword | 3 | 60% | 0% | 3 |
6 | METABOLIC TUMOUR VOLUME | Author keyword | 2 | 32% | 1% | 6 |
7 | HEAD AND NECK SQUAMOUS | Author keyword | 2 | 67% | 0% | 2 |
8 | RECURRENT LARYNGEAL CARCINOMA | Author keyword | 2 | 50% | 0% | 3 |
9 | TOTAL LESION GLYCOLYSIS | Author keyword | 1 | 14% | 1% | 10 |
10 | COINCIDENCE DETECTION EMISSION TOMOGRAPHY | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POSTRADIOTHERAPY NECK | 61 | 95% | 2% | 20 |
2 | PLANNED NECK | 54 | 83% | 3% | 30 |
3 | CLINICALLY POSITIVE NECK | 33 | 71% | 3% | 27 |
4 | EXTRACRANIAL HEAD | 15 | 42% | 3% | 28 |
5 | RECURRENT HEAD | 14 | 20% | 7% | 63 |
6 | 2 F 18FLUORO 2 DEOXY D GLUCOSE | 12 | 39% | 3% | 25 |
7 | N POSITIVE NECK | 12 | 86% | 1% | 6 |
8 | N2 N3 NECK | 9 | 83% | 1% | 5 |
9 | PREVIOUSLY UNTREATED HEAD | 9 | 83% | 1% | 5 |
10 | NODAL DISEASE | 9 | 52% | 1% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
PET imaging biomarkers in head and neck cancer | 2015 | 3 | 78 | 38% |
A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy | 2008 | 92 | 53 | 81% |
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-Analysis | 2014 | 7 | 33 | 58% |
PET/CT in head and neck oncology: State-of-the-art 2013 | 2014 | 6 | 13 | 62% |
Current status of FDG-PET for head and neck cancer | 2008 | 37 | 22 | 77% |
Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma | 2011 | 18 | 49 | 84% |
Comparison between anatomical cross-sectional imaging and F-18-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview | 2014 | 4 | 55 | 53% |
The Role of Neck Dissection after Radical Chemoradiation for Locally Advanced Head and Neck Cancer: Should We Move Back? | 2013 | 4 | 62 | 82% |
Fluorodeoxyglucose-Positron-Emission Tomography Imaging of Head and Neck Squamous Cell Cancer | 2010 | 29 | 44 | 52% |
The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease | 2012 | 9 | 95 | 71% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEAD NECK RADIAT ONCOL CANC SERV | 1 | 100% | 0.2% | 2 |
2 | NEOPLAST RELATED DISORDERS | 1 | 50% | 0.2% | 2 |
3 | RADIAT CELLULAR ONCOL BIOPHYS | 1 | 100% | 0.2% | 2 |
4 | RADIAT ONCOL RADIAT MOL SCI | 1 | 40% | 0.2% | 2 |
5 | THORAC HEAD NECK MED | 1 | 40% | 0.2% | 2 |
6 | WCU CONCERGENCE SCI TECHNOL | 1 | 40% | 0.2% | 2 |
7 | SURG HEAD NECK SERV | 1 | 23% | 0.3% | 3 |
8 | ABT NUCL MED ENDOKRINOL | 1 | 50% | 0.1% | 1 |
9 | ASAHI GEN HOSP | 1 | 50% | 0.1% | 1 |
10 | CENT SECRETARIAT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000220842 | LARYNX CT//LARYNX NEOPLASMS//TONGUE NEOPLASMS |
2 | 0.0000210264 | SUV//STANDARDIZED UPTAKE VALUE//LUNG NEOPLASMS EMISSION CT ECT |
3 | 0.0000164641 | ELECTIVE NECK DISSECTION//NECK DISSECTION//SELECTIVE NECK DISSECTION |
4 | 0.0000152860 | NARROW BAND IMAGING//GASTRIC TUBE CANCER//INTRAEPITHELIAL PAPILLARY CAPILLARY LOOP |
5 | 0.0000147511 | CANCER OF UNKNOWN PRIMARY//UNKNOWN PRIMARY//CARCINOMA OF UNKNOWN PRIMARY |
6 | 0.0000141785 | HEAD AND NECK CANCER//INDUCTION CHEMOTHERAPY//LOCALLY ADVANCED HEAD AND NECK CANCER |
7 | 0.0000125340 | ATSUCHI MEM RADIOL//HAMAMATSU MED IMAGING//PET ANGIOGRAPHY |
8 | 0.0000107875 | C 11 METHIONINE//O 2 F 18FLUOROETHYL L TYROSINE//FET PET |
9 | 0.0000095133 | F 18 FLT//F 18FLT//FLT |
10 | 0.0000092447 | PET MRI//PET MR//ATTENUATION CORRECTION |